These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

261 related articles for article (PubMed ID: 11745186)

  • 21. Molecular and cytogenetic characterization of a t(1;10;21) translocation in the human papillary thyroid cancer cell line TPC-1 expressing the ret/H4 chimeric transcript.
    Jossart GH; Greulich KM; Siperstein AE; Duh Q; Clark OH; Weier HU
    Surgery; 1995 Dec; 118(6):1018-23. PubMed ID: 7491517
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Molecular genetic evidence for the independent origin of multifocal papillary tumors in patients with papillary renal cell carcinomas.
    Jones TD; Eble JN; Wang M; MacLennan GT; Delahunt B; Brunelli M; Martignoni G; Lopez-Beltran A; Bonsib SM; Ulbright TM; Zhang S; Nigro K; Cheng L
    Clin Cancer Res; 2005 Oct; 11(20):7226-33. PubMed ID: 16243792
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Karyotypic characterization of colorectal adenocarcinomas.
    Bardi G; Sukhikh T; Pandis N; Fenger C; Kronborg O; Heim S
    Genes Chromosomes Cancer; 1995 Feb; 12(2):97-109. PubMed ID: 7535093
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Nonrandom chromosomal aberrations and cytogenetic heterogeneity in gallbladder carcinomas.
    Gorunova L; Parada LA; Limon J; Jin Y; Hallén M; Hägerstrand I; Iliszko M; Wajda Z; Johansson B
    Genes Chromosomes Cancer; 1999 Dec; 26(4):312-21. PubMed ID: 10534766
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Chromosomal aberrations by comparative genomic hybridization in hürthle cell thyroid carcinomas are associated with tumor recurrence.
    Wada N; Duh QY; Miura D; Brunaud L; Wong MG; Clark OH
    J Clin Endocrinol Metab; 2002 Oct; 87(10):4595-601. PubMed ID: 12364440
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Association of allelic loss on 1q, 4p, 7q, 9p, 9q, and 16q with postoperative death in papillary thyroid carcinoma.
    Kitamura Y; Shimizu K; Tanaka S; Ito K; Emi M
    Clin Cancer Res; 2000 May; 6(5):1819-25. PubMed ID: 10815903
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Aneuploidy in oncocytic lesions of the thyroid gland: diffuse accumulation of mitochondria within the cell is associated with trisomy 7 and progressive numerical chromosomal alterations.
    Dettori T; Frau DV; Lai ML; Mariotti S; Uccheddu A; Daniele GM; Tallini G; Faa G; Vanni R
    Genes Chromosomes Cancer; 2003 Sep; 38(1):22-31. PubMed ID: 12874783
    [TBL] [Abstract][Full Text] [Related]  

  • 28. RET rearrangements in papillary thyroid carcinomas and adenomas detected by interphase FISH.
    Cinti R; Yin L; Ilc K; Berger N; Basolo F; Cuccato S; Giannini R; Torre G; Miccoli P; Amati P; Romeo G; Corvi R
    Cytogenet Cell Genet; 2000; 88(1-2):56-61. PubMed ID: 10773666
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Identification of a clustering of chromosomal breakpoints in the analysis of 203 human primary solid tumor non specific karyotypic rearrangements.
    Teyssier JR; Ferre D
    Anticancer Res; 1992; 12(3):997-1004. PubMed ID: 1622159
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Loss of heterozygosity on chromosome 1p in thyroid adenoma and medullary carcinoma, but not in papillary carcinoma.
    Kubo K; Yoshimoto K; Yokogoshi Y; Tsuyuguchi M; Saito S
    Jpn J Cancer Res; 1991 Oct; 82(10):1097-103. PubMed ID: 1683348
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cytogenetic profile of 109 lipomas.
    Sreekantaiah C; Leong SP; Karakousis CP; McGee DL; Rappaport WD; Villar HV; Neal D; Fleming S; Wankel A; Herrington PN
    Cancer Res; 1991 Jan; 51(1):422-33. PubMed ID: 1988102
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Follicular thyroid carcinoma: chromosome analysis of 19 cases.
    Roque L; Clode A; Belge G; Pinto A; Bartnitzke S; Santos JR; Thode B; Bullerdiek J; Castedo S; Soares J
    Genes Chromosomes Cancer; 1998 Mar; 21(3):250-5. PubMed ID: 9523201
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Analysis of 35 cases of localized and diffuse tenosynovial giant cell tumor: a report from the Chromosomes and Morphology (CHAMP) study group.
    Sciot R; Rosai J; Dal Cin P; de Wever I; Fletcher CD; Mandahl N; Mertens F; Mitelman F; Rydholm A; Tallini G; van den Berghe H; Vanni R; Willén H
    Mod Pathol; 1999 Jun; 12(6):576-9. PubMed ID: 10392632
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cytogenetic characterization of a new human papillary thyroid carcinoma permanent cell line (GLAG-66).
    Antonini P; Linares G; Gaillard N; Venuat AM; Schlumberger M; Travagli JP; Caillou B; Berger R; Parmentier C
    Cancer Genet Cytogenet; 1993 Jun; 67(2):117-22. PubMed ID: 8330267
    [TBL] [Abstract][Full Text] [Related]  

  • 35. RET/PTC fusion gene rearrangements in Japanese thyroid carcinomas.
    Nibu K; Otsuki N; Nakao K; Sugasawa M; Rothstein JL
    Eur Arch Otorhinolaryngol; 2005 May; 262(5):368-73. PubMed ID: 15368067
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Evidence for a 3p25 breakpoint hot spot region in thyroid tumors of follicular origin.
    Drieschner N; Belge G; Rippe V; Meiboom M; Loeschke S; Bullerdiek J
    Thyroid; 2006 Nov; 16(11):1091-6. PubMed ID: 17123335
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cytogenetics and molecular genetics of carcinomas arising from thyroid epithelial follicular cells.
    Pierotti MA; Bongarzone I; Borello MG; Greco A; Pilotti S; Sozzi G
    Genes Chromosomes Cancer; 1996 May; 16(1):1-14. PubMed ID: 9162191
    [TBL] [Abstract][Full Text] [Related]  

  • 38. High prevalence of BRAF gene mutation in papillary thyroid carcinomas and thyroid tumor cell lines.
    Xu X; Quiros RM; Gattuso P; Ain KB; Prinz RA
    Cancer Res; 2003 Aug; 63(15):4561-7. PubMed ID: 12907632
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Molecular evidence for the same clonal origin of multifocal papillary thyroid carcinomas.
    McCarthy RP; Wang M; Jones TD; Strate RW; Cheng L
    Clin Cancer Res; 2006 Apr; 12(8):2414-8. PubMed ID: 16638846
    [TBL] [Abstract][Full Text] [Related]  

  • 40. RET/PTC oncogene activation defines a subset of papillary thyroid carcinomas lacking evidence of progression to poorly differentiated or undifferentiated tumor phenotypes.
    Tallini G; Santoro M; Helie M; Carlomagno F; Salvatore G; Chiappetta G; Carcangiu ML; Fusco A
    Clin Cancer Res; 1998 Feb; 4(2):287-94. PubMed ID: 9516913
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.